2024-511286-11-00招募中1 期
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- Hifibio Inc.
- 入组人数
- 188
- 试验地点
- 3
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Regulatory Submissions
Scientific
Hifibio Inc.
研究点 (3)
Loading locations...
相似试验
招募中
1 期
A study of HFB200603 as a single agent and in combination with Tislelizumab in patients with advanced solid tumors2022-502891-22-00Hifibio Inc.96
已完成
1 期
A study to learn how BAY2927088 is taken up and handled by the body in healthy male participants2022-502771-38-00Bayer AG, Bayer AG8
已完成
1 期
A research study looking at how the compound NNC0194-0499 works with birth control pills in women not able to bear children.2023-503595-24-00Novo Nordisk A/S30
招募中
1 期
A study to see the effect of NNC0194-0499 alone or in combination with semaglutide on blood sugar control in people living with type 1 diabetes.2024-519533-38-00Novo Nordisk A/S96
已完成
1 期
[HIBOU] : A phase I, single-center, randomized, double-blind, single-dose escalation, placebo-controlled clinical study to evaluate the safety, tolerability and pharmacokinetics of IMP21052 administered intravenously in three groups of healthy male and female volunteers2023-509035-30-00Direction Centrale Du Service De Sante Des Armees40